🇺🇸 FDA
Patent

US 10293005

Use of gram negative species to treat atopic dermatitis

granted A61KA61K35/74A61K9/0014

Quick answer

US patent 10293005 (Use of gram negative species to treat atopic dermatitis) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue May 21 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K35/74, A61K9/0014, A61K9/06, A61P